MetLife (MET) Announces $3B Share Repurchase Plan

MetLife, Inc. (NYSE: MET) today announced that its board of directors has approved a new $3 billion authorization for the company to repurchase its common stock. The new authorization is incremental to the $475 million remaining under the company’s prior authorization announced in December 2020.

“We continue to pursue a balanced, long-term approach to creating shareholder value,” said MetLife President and CEO Michel Khalaf. “Last year, we invested approximately $5 billion to drive profitable growth both organically and through acquisition. This April, we announced a 4.3% increase in our common dividend. And today’s announcement reflects our commitment to returning excess capital to shareholders.”

You May Also Be Interested In

• Cosmos Health buyback reaches 3.42M shares at ~$650,000 spent
• Propanc Biopharma launches $5M share repurchase program
• Two Harbors stockholders approve CrossCountry Mortgage merger at $12 a share